Two inexpensive, widely available medications provided modest short-term relief from fatigue in people with long COVID, ...

Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long Covid ...

Ten weeks of cognitive rehabilitation can help people with long Covid symptoms such as brain fog achieve their goals in returning to work and hobbies, finds a new clinical trial led by University ...

Martinez had been living with long COVID for 18 months when he was referred to emergency medicine specialist Craig Lindsey’s hyperbaric center in Santa Fe, N.M. A 49-year-old court professional, ...

A small trial finds that the technique helps some of the condition's brain symptoms.

But researchers say trial results highlight the value of long COVID specialist care ...

GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health ...

To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...

Metformin does not significantly reduce the risk for long COVID at 6 months in low-risk adults with high baseline immunity to the virus.

Researchers evaluated whether corticosteroid treatment during acute SARS-CoV-2 infection decreases the risk for long COVID in pediatric patients.

Early metformin treatment in mild-to-moderate COVID may not prevent long-term symptoms but is linked to relatively fewer clinician-diagnosed cases, a study finds.